Skip to main content
Prime Securities Ltd. logo

Prime Securities Ltd. — Investor Relations & Filings

Ticker · PRIMESECU ISIN · INE032B01021 LEI · 335800M8UW96ZOVMGJ80 BSE.NS Financial and insurance activities
Open in API
Filings indexed 1,151 across all filing types
Latest filing 2022-11-10 Regulatory Filings
Country IN India
Listing BSE.NS PRIMESECU

About Prime Securities Ltd.

https://primesec.com/

Prime Securities Ltd. provides a range of corporate advisory and investment banking services. The firm specializes in mergers and acquisitions, private equity syndication, and capital restructuring for a diverse client base. Its service portfolio includes equity capital market transactions, debt syndication, and structured finance solutions. Prime Securities Ltd. focuses on delivering strategic financial guidance and customized engineering to facilitate growth and optimize capital structures. The company supports clients through complex financial transitions, offering expertise in institutional brokerage and wealth management. By leveraging deep market insights and an advisory-led approach, the firm aims to enhance shareholder value and provide comprehensive support for corporate growth initiatives and strategic decision-making.

Recent filings

Filing Released Lang Actions
Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding compliance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It encloses disclosures of related party transactions on a consolidated basis for the half year ended September 30, 2022. The content includes detailed tables of related party transactions, including loans, remuneration, and fees, for the half-year period. The document is dated November 10, 2022, and is a formal regulatory disclosure rather than a full financial report or earnings release. It is a regulatory filing to comply with listing obligations and disclosure requirements, not an annual or interim report, earnings release, or other specific report type. The document length is 4158 characters, which is relatively short and focused on regulatory compliance disclosures. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2022-11-10 English
General updates
Capital/Financing Update Classification · 95% confidence The document is a formal disclosure submitted to stock exchanges (BSE and NSE) pursuant to Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It specifically provides a Statement of Nil Deviation or Variation in utilization of funds raised through a Preferential Issue for the quarter ended September 30, 2022. The content focuses on compliance reporting about the use of raised funds, confirming no deviation or variation. It is not a full financial report, audit report, or earnings release, but a regulatory compliance disclosure related to capital raising and fund utilization. This fits the category of Capital/Financing Update (CAP) as it relates to updates on fundraising and capital usage. The document length is about 5240 characters, containing substantive information rather than a mere announcement or certification, so it is not RPA or RNS. Therefore, the best classification is CAP with high confidence.
2022-11-09 English
Disclosure in terms of Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Statement of Nil Deviation or Variation
Regulatory Filings Classification · 95% confidence The document is a statement submitted pursuant to Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the 'Statement of Nil Deviation or Variation' in utilization of funds raised for the quarter ended September 30, 2022. It reports on the use of funds raised through a preferential issue and confirms no deviation or variation. The document is a regulatory disclosure related to capital raising and fund utilization compliance, not a full financial report or earnings release. It is a compliance filing under SEBI regulations, reporting on capital use but not announcing new financing or capital structure changes. Given the nature and regulatory context, this fits best under Regulatory Filings (RNS) as it is a compliance disclosure and does not constitute a Capital/Financing Update (CAP) or other report types. The document length is short and it is a formal regulatory disclosure letter rather than a detailed report or presentation.
2022-11-09 English
Unaudited Financial Results for the Quarter ended September 2022
Regulatory Filings
2022-11-09 English
Outcome of Board Meeting
Regulatory Filings
2022-11-09 English
Outcome of Board Meeting held on 09-Nov-2022 to consider financial statements for the period ended September 2022
Regulatory Filings
2022-11-09 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.